1066 related articles for article (PubMed ID: 26276068)
1. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H
Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068
[TBL] [Abstract][Full Text] [Related]
2. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
3. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
[TBL] [Abstract][Full Text] [Related]
4. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
5. Impact of cardiac resynchronisation therapy on physical ability and quality of life in patients with chronic heart failure.
Kloch Badełek M; Klocek M; Czarnecka D; Wojciechowska W; Wiliński J; Kawecka Jaszcz K
Kardiol Pol; 2012; 70(6):581-8. PubMed ID: 22718376
[TBL] [Abstract][Full Text] [Related]
6. Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study.
Piotrowicz E; Zieliński T; Bodalski R; Rywik T; Dobraszkiewicz-Wasilewska B; Sobieszczańska-Małek M; Stepnowska M; Przybylski A; Browarek A; Szumowski Ł; Piotrowski W; Piotrowicz R
Eur J Prev Cardiol; 2015 Nov; 22(11):1368-77. PubMed ID: 25261268
[TBL] [Abstract][Full Text] [Related]
7. Exercise training program in patients with NYHA III class systolic heart failure - Parallel comparison to the effects of resynchronization therapy.
Smolis-Bąk E; Chwyczko T; Kowalik I; Borowiec A; Maciąg A; Szwed H; Dąbrowski R
Adv Med Sci; 2019 Sep; 64(2):241-245. PubMed ID: 30822631
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
9. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
[TBL] [Abstract][Full Text] [Related]
10. Ventilatory gas exchange and early response to cardiac resynchronization therapy.
Kim CH; Olson LJ; Shen WK; Cha YM; Johnson BD
J Heart Lung Transplant; 2015 Nov; 34(11):1430-5. PubMed ID: 26163155
[TBL] [Abstract][Full Text] [Related]
11. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure.
Versteeg H; van den Broek KC; Theuns DA; Mommersteeg PM; Alings M; van der Voort PH; Jordaens L; Pedersen SS
Am J Cardiol; 2011 Oct; 108(8):1155-9. PubMed ID: 21821227
[TBL] [Abstract][Full Text] [Related]
12. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
[TBL] [Abstract][Full Text] [Related]
13. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure.
Veazie PJ; Noyes K; Li Q; Hall WJ; Buttaccio A; Thevenet-Morrison K; Moss AJ
J Am Coll Cardiol; 2012 Nov; 60(19):1940-4. PubMed ID: 23062542
[TBL] [Abstract][Full Text] [Related]
15. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.
Chwyczko T; Sterliński M; Maciag A; Firek B; Labecka A; Jankowska A; Kośmicki M; Kowalik I; Malczewska B; Szwed H
Kardiol Pol; 2008 Apr; 66(4):406-12; discussion 413-4. PubMed ID: 18473269
[TBL] [Abstract][Full Text] [Related]
16. High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial.
Spee RF; Niemeijer VM; Schoots T; Tuinenburg A; Houthuizen P; Wijn PF; Doevendans PA; Kemps HM
Int J Cardiol; 2020 Jan; 299():169-174. PubMed ID: 31353158
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
18. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
[TBL] [Abstract][Full Text] [Related]
19. Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial.
Geller JC; Lewalter T; Bruun NE; Taborsky M; Bode F; Nielsen JC; Stellbrink C; Schön S; Mühling H; Oswald H; Reif S; Kääb S; Illes P; Proff J; Dagres N; Hindricks G;
Clin Res Cardiol; 2019 Oct; 108(10):1117-1127. PubMed ID: 30874886
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
